Scandinavian ChemoTech AB updates on sales, clinical- and R&D projects and future milestones
With this newsletter, ChemoTech wishes to provide our various stakeholders with an update on our commercialisation process as well as our clinical- and R&D projects for both Human- and Animal Care.Human Care We are very bullish with our future on Human Care given our technology and its effects as well as our business model. Our main market focus remains on India. Given the huge number of cases, our focus area of head and neck at this stage and the cancer situation in India today, our technology is uniquely placed to gain a significant part of this market. Indian customers today adapt